000 01454 a2200421 4500
005 20250516062646.0
264 0 _c20160712
008 201607s 0 0 eng d
022 _a1941-6636
024 7 _a10.1007/s12029-011-9338-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIoannidis, Orestis
245 0 0 _aPrimary Signet Ring Cell Anal Adenocarcinoma.
_h[electronic resource]
260 _bJournal of gastrointestinal cancer
_cSep 2012
300 _aS168-70 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged, 80 and over
650 0 4 _aAntimetabolites, Antineoplastic
_xtherapeutic use
650 0 4 _aAnus Neoplasms
_xdrug therapy
650 0 4 _aCarcinoma, Signet Ring Cell
_xdrug therapy
650 0 4 _aColonoscopy
650 0 4 _aCombined Modality Therapy
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xtherapeutic use
650 0 4 _aGastroscopy
650 0 4 _aHumans
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aPrognosis
700 1 _aPapaemmanouil, Styliani
700 1 _aParaskevas, George
700 1 _aChatzopoulos, Stavros
700 1 _aKotronis, Anastasios
700 1 _aPapadimitriou, Nikolaos
700 1 _aMakrantonakis, Apostolos
700 1 _aKakoutis, Emmanouil
773 0 _tJournal of gastrointestinal cancer
_gvol. 43 Suppl 1
_gp. S168-70
856 4 0 _uhttps://doi.org/10.1007/s12029-011-9338-1
_zAvailable from publisher's website
999 _c21275711
_d21275711